IC
PRCT icon

Inscription Capital’s Procept Biorobotics PRCT Stock Holding History

Inscription Capital’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$920K Buy
40,736
+2,654
+7% +$66.5K 0.08% 237
2026
Q1 		$952K Buy
38,082
+21,015
+123% +$592K 0.1% 203
2025
Q4 		$537K Buy
+17,067
New +$566K 0.06% 343

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Inscription Capital's PRCT Position: Q2 2026 in Review

Inscription Capital increased its Procept Biorobotics (PRCT) stake by 7% in Q2 2026, buying an estimated $66.5K and bringing the position to 40,736 shares worth $920K. The position accounts for 0.08% of the portfolio, ranked #237.

Inscription Capital first reported a position in PRCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $952K in Q1 2026. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Inscription Capital held 40,736 shares of Procept Biorobotics worth $920K as of Q2 2026.
  • Inscription Capital bought 2,654 Procept Biorobotics shares in Q2 2026, an estimated $66.5K.
  • Procept Biorobotics made up 0.08% of Inscription Capital's portfolio in Q2 2026, its #237 holding.
  • Inscription Capital first reported a position in Procept Biorobotics in Q4 2025 and has held it in 3 quarters since.
  • Inscription Capital's Procept Biorobotics position peaked at $952K in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.